Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Chemed Corporation (CHE : NYSE)

• Company Description    Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. Number of Employees: 15,695

• Price / Volume Information    Yesterday's Closing Price: $427.86 Daily Weekly Monthly 20 Day Moving Average: 124,553 shares Shares Outstanding: 14.16 (millions) Market Capitalization: $6,060.29 (millions) Beta: 0.44 52 Week High: $623.61 52 Week Low: $408.42 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.84% 1.01% 12 Week -0.82% -2.42% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 255 EAST FIFTH STREET SUITE 2600 - CINCINNATI,OH 45202 USA ph: 513-762-6690 fax: 513-762-6590 None http://www.chemed.com

• General Corporate Information    Officers Kevin J. McNamara - President and Chief Executive Officer Michael D. Witzeman - Vice President; Chief Financial Officer; and Contr Ron DeLyons - Directors Patrick P. Grace - Directors Christopher J. Heaney - Directors Peer Information Chemed Corporation (CMTI) Chemed Corporation (CMWLQ) Chemed Corporation (AHG.) Chemed Corporation (ROIX) Chemed Corporation (M.DCE) Chemed Corporation (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 16359R103 SIC: 8082 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/25/26 Share - Related Items Shares Outstanding: 14.16 Most Recent Split Date: 5.00 (2.00:1) Beta: 0.44 Market Capitalization: $6,060.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.56% Current Fiscal Quarter EPS Consensus Estimate: $5.37 Indicated Annual Dividend: $2.40 Current Fiscal Year EPS Consensus Estimate: $23.42 Payout Ratio: 0.12 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.04 Estmated Long-Term EPS Growth Rate: 8.77% Last Dividend Paid: 11/17/2025 - $0.60 Next EPS Report Date: 02/25/26

• Fundamental Ratios P/E Current FY Estimate: 18.26 Trailing 12 Months: 21.29 PEG Ratio: 2.08 Price Ratios Price/Book: 5.63 Price/Cash Flow: 16.64 Price / Sales: 2.39 EPS Growth vs. Year Ago Period: -7.32% vs. Previous Quarter: 31.73% Sales Growth vs. Year Ago Period: 3.09% vs. Previous Quarter: 0.99% ROE 12/31/25 - - 09/30/25 - 25.89 06/30/25 - 25.83 ROA 12/31/25 - - 09/30/25 - 17.59 06/30/25 - 17.77 Current Ratio 12/31/25 - - 09/30/25 - 1.35 06/30/25 - 1.86 Quick Ratio 12/31/25 - - 09/30/25 - 1.33 06/30/25 - 1.83 Operating Margin 12/31/25 - - 09/30/25 - 11.70 06/30/25 - 12.17 Net Margin 12/31/25 - - 09/30/25 - 11.02 06/30/25 - 11.56 Pre-Tax Margin 12/31/25 - - 09/30/25 - 14.64 06/30/25 - 15.44 Book Value 12/31/25 - - 09/30/25 - 76.01 06/30/25 - 82.25 Inventory Turnover 12/31/25 - - 09/30/25 - 203.60 06/30/25 - 190.32 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©